Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors

标题
Abstract C43: Safety, tolerability, and clinical activity of MRX34, the first-in-class liposomal miR-34 mimic, in patients with advanced solid tumors
作者
关键词
-
出版物
MOLECULAR CANCER THERAPEUTICS
Volume 14, Issue 12 Supplement 2, Pages C43-C43
出版商
American Association for Cancer Research (AACR)
发表日期
2016-05-20
DOI
10.1158/1535-7163.targ-15-c43

向作者/读者发起求助以获取更多资源

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started